Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Mn-promoted synthesis of indole-isoquinolinone derivatives. High yield, mild conditions. Cost-effective solution for API intermediates.
Patent CN115353511A details a safe, multicomponent Pd-catalyzed carbonylation route for indolinone-imidazole hybrids, offering cost reduction in API manufacturing.
Patent CN111675662B reveals a novel iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering cost-effective and scalable solutions for pharmaceutical manufacturing.
A novel one-pot palladium-catalyzed method for synthesizing bioactive quinazolinones using nitro compounds, offering significant cost and safety advantages.
Novel glucose-based synthesis for 3-trifluoromethyl-1,2,4-triazoles offers cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains.
Patent CN113307790B reveals a metal-free oxidative cyclization route for high-purity triazole intermediates, offering significant cost reduction and scalable supply chain reliability.
Efficient KOH-promoted synthesis of 2-arylquinazolinones. High yield, air oxidant, cost-effective pharmaceutical intermediate manufacturing solution for global buyers.
Patent CN116947597B reveals metal-free synthesis for o-iodophenyl acetylene. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing processes.
Patent CN111635370A details a green photocatalytic route for 3-alkylquinoxalinone derivatives, offering mild conditions and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111423381B reveals a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering reliable supply and cost-effective API intermediate manufacturing.
Patent CN115353511A details a novel multi-component Pd-catalyzed carbonylation for synthesizing indolinone-imidazole hybrids, offering cost-effective routes for API intermediates.
Patent CN112028841A reveals a catalyst-free visible light method for high-yield quinoxalinone synthesis, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111423381B details a mild Pd-catalyzed route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply with enhanced cost efficiency.
Patent CN116143689A details a metal-free route to tetrasubstituted pyridines using imidazole hydrochloride, offering high yields and scalability for pharmaceutical intermediates.
Novel patent CN113651788B enables efficient room temperature synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing globally.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity and cost-effective synthesis for asymmetric catalysis.
This patent details a novel one-step synthesis route for spiro pyrroloindolone derivatives offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing processes globally.
Patent CN118126005B reveals a metal-free route for fluorinated heterocycles, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN108610278A details Rh(III) catalyzed synthesis offering mild conditions and streamlined operations for cost reduction in fine chemical manufacturing supply chains.
Patent CN105175370A reveals a novel palladium-catalyzed route for Olaparib intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.